Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring mandibular canal variations using CBCT: A study on clinical relevance and risk assessment.

Bioinformation·2026
Same author

The Impact of Low-Protein Diet on the Molecular and Cellular Development of the Fetal Kidney.

Journal of the American Society of Nephrology : JASN·2026
Same author

α4 Integrin blockade impairs CD8+ T cell neuroimmune surveillance following SIV infection.

The Journal of clinical investigation·2026
Same author

Western Diet Dampens T Regulatory Cell Function to Fuel Hepatic Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Cells·2026
Same author

Magnetic Resonance Imaging Evaluation of Temporomandibular Joint Involvement in Ankylosing Spondylitis Patients.

Journal of orthopaedic case reports·2026
Same author

Nucleoside diphosphate kinase (LdNDK2): A metacyclogenesis-regulating kinase essential for Leishmania parasite survival within eukaryotic host cells.

Microbial pathogenesis·2025

Related Experiment Video

Updated: Jul 8, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Hepatosystemic T cell licensing in MASLD-associated neuroinflammation.

Britton Spencer Cartee1, Fabiola Diniz1, Ravi Rai2

  • 1University of Pittsburgh, Pathology, Pennsylvania, United States, Pittsburgh.

Seminars in Liver Disease
|July 6, 2026
PubMed
Summary

The liver influences the brain via T cells, a process termed hepatosystemic inflammation. This liver-brain axis links metabolic dysfunction-associated steatotic liver disease to neuroinflammation and cognitive decline.

Related Experiment Videos

Last Updated: Jul 8, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

Area of Science:

  • Immunology
  • Neuroscience
  • Hepatology

Background:

  • The liver-brain axis involves complex signaling pathways.
  • Hepatic inflammation in metabolic dysfunction-associated steatotic liver disease (MASLD) significantly impacts systemic immunity.
  • Hepatic lymphatic output is a major source of circulating T cells and cytokines.

Purpose of the Study:

  • To propose T lymphocytes as key effectors in hepatosystemic inflammation.
  • To elucidate the role of T cell licensing in linking liver disease to neuroinflammation.
  • To identify therapeutic targets within the liver-brain immune axis.

Main Methods:

  • Conceptual framework development based on existing literature.
  • Analysis of immune cell trafficking and signaling pathways.
  • Integration of hepatology, immunology, and neuroscience principles.

Main Results:

  • Hepatosystemic inflammation, driven by liver disease, generates peripheral signals that may prime T cells for CNS entry.
  • Neuroinflammatory signals at CNS barriers may facilitate T cell access.
  • T cell licensing by hepatosystemic signals is proposed as the immune arm of the liver-brain axis.

Conclusions:

  • T cell licensing by hepatosystemic signals bridges metabolic liver disease and neuroimmune dysfunction.
  • This mechanism connects liver inflammation to cognitive decline.
  • Candidate therapeutic targets along this cascade are identified for future research.